Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Up 297.4% in April

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 6,339 shares, an increase of 297.4% from the April 15th total of 1,595 shares. Based on an average trading volume of 39,192 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.3% of the company’s shares are sold short.

Arcadia Biosciences Trading Up 0.9%

Shares of RKDA traded up $0.01 during trading hours on Thursday, hitting $1.07. The company had a trading volume of 140,119 shares, compared to its average volume of 34,363. The company has a market capitalization of $2.20 million, a PE ratio of -0.62 and a beta of 0.52. Arcadia Biosciences has a one year low of $0.89 and a one year high of $6.71. The company’s fifty day moving average price is $1.41 and its two-hundred day moving average price is $2.33.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings results on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing the consensus estimate of ($0.80) by ($1.31). The company had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a positive return on equity of 37.36% and a negative net margin of 48.15%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Arcadia Biosciences from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 6th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.